🟢 100/100

This product looks safe

  • No ingredients exceed tolerable upper intake levels
  • 67% of ingredients have research evidence
A Label Compliance Grade

Product Label

📸

Have a supplement label? Find it here.

Upload a photo of any supplement label to search our database of 92,312 products.

Label Data

2 Tablet(s) Serving Size
30 Servings
Other Combinations Product Type
67% Evidence Coverage

Supplement Facts — Evidence Check

📊 Market median: 600.0mg (7 products) 📚 39 studies (Tier A: 2, B: 13)
This product: 600mg
📊 Market median: 500.0mg (861 products) 📚 60 studies (Tier A: 4, B: 13)
This product: 500mg
250 mg
📊 208.3× RDA — above typical dose 📚 76 studies (Tier A: 0, B: 33)
RDA 1.2mg This product: 250mg
📊 Market median: 200.0mg (198 products) 📚 6 studies — no high-quality reviews
This product: 200mg
✅ Within RDA (0.5× RDA of 420 mg)
RDA 420mg This product: 194mg UL 350mg
50 mcg (2000% DV)
📊 20.8× RDA — above typical dose 📚 138 studies (Tier A: 1, B: 44)
RDA 0.0024mg This product: 0.05mg

Other Ingredients

Acacia Gum

Label Claims — Verification

All Other
All Other (96% of products) Structure/Function (81% of products) Nutrient (19% of products) No Claim (3% of products)

Target Groups

Adult (18 - 50 Years)

Product Information

📋 Directions for Use

Directions: Adults. Take two tablets per day.

⚠️ Warnings & Precautions

Precautions: Do not exceed the recommended daily dose. This product is a nutritional supplement and should not be used to replace a varied, balanced diet or healthy lifestyle.

Keep out of young children's reach.

As with all nutritional supplements, consult a health professional before taking if you are pregnant, breastfeeding or suffer from a health problem.

Additional Information

Store away from light, heat and humidity.

RDA

Product Details

UPC / SKU 5 453003 828358
DSLD Entry Date 2025-06-25
Product Type Other Combinations
Form Tablet or Pill
Brand SuperSmart
DSLD ID 332467
Data Updated 2026-04-11

Research Evidence

41 Research Sources
51 Avg Quality Score
19 Rct
13 Meta Analysis
9 Clinical Trial
B N-acetylcysteine as an adjuvant therapy for Helicobacter pylori eradication
Meta Analysis The Cochrane database of systematic reviews 2019
B Effect of high-dose N-acetylcysteine on exacerbations and lung function in patients with mild-to-moderate COPD: a double-blind, parallel group, multicentre randomised clinical trial
Rct Nature communications 2024
B N-acetylcysteine for non-paracetamol (acetaminophen)-related acute liver failure
Meta Analysis The Cochrane database of systematic reviews 2020
B Influence of N-acetylcysteine on chronic bronchitis or COPD exacerbations: a meta-analysis
Meta Analysis European respiratory review : an official journal of the European Respiratory Society 2015
B A randomised controlled trial of a mitochondrial therapeutic target for bipolar depression: mitochondrial agents, N-acetylcysteine, and placebo
Rct BMC medicine 2019
B Efficacy of N-acetylcysteine for patients with depression: An updated systematic review and meta-analysis
Meta Analysis General hospital psychiatry 2024
B Cysteine, cystine or N-acetylcysteine supplementation in parenterally fed neonates
Meta Analysis The Cochrane database of systematic reviews 2006
B N-acetylcysteine as an adjunctive treatment for bipolar depression: A systematic review and meta-analysis of randomized controlled trials
Meta Analysis Bipolar disorders 2021
B N-acetylcysteine as an adjunctive treatment for bipolar depression and major depressive disorder: a systematic review and meta-analysis of double-blind, randomized placebo-controlled trials
Meta Analysis Psychopharmacology 2020
B N-acetylcysteine Treatment in Chronic Obstructive Pulmonary Disease (COPD) and Chronic Bronchitis/Pre-COPD: Distinct Meta-analyses
Meta Analysis Archivos de bronconeumologia 2024
View all evidence for Nac →

Compare Similar Products

View all Nac products →